CNL Strategic Capital LLC, a publicly registered non-traded limited liability company, acquired a majority equity stake and made a concurrent debt investment in TacMed Solutions, a developer and manufacturer of customized emergency response technology.
At the closing of the transaction, all the remaining TacMed equity is owned by members of TacMed’s executive team and founder. This is the 12th company in CNL Strategic Capital’s portfolio.
Founded in 2003 and headquartered in Anderson, South Carolina, TacMed designs, develops and manufactures medical products that equip, train and protect professionals in pre-hospital and emergency trauma situations.
TacMed’s suite of traumatic injury products, hemorrhage control tourniquets, immobilization tools and critical care kits serve first responders, military, law enforcement and civilian public safety operations. The company’s medical simulation training solutions combine advanced technology and durable materials to offer customers the highest fidelity training simulators and provide realistic replicas for emergency medical personnel training exercises.
CNL Strategic Capital acquires controlling equity stakes in combination with loan positions in middle-market businesses. The company is externally managed by CNL Strategic Capital Management LLC and Levine Leichtman Strategic Capital LLC. The company has raised more than $490 million in investor equity via two public offerings, the first of which was declared effective in March 2018. One Nov. 1, 2021, CNL Strategic Capital launched a follow-on public offering of up to $1.1 billion.
Click here to visit The DI Wire directory page.